Acurx Pharmaceuticals shares are trading lower by 30% during Friday’s session. The company announced a $1.1 million registered direct offering.
Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30%
More from STOCKMore posts in STOCK »
- Tech Shift Revives European Stocks This Week
- Binance data highlights Bitcoin price drop despite surge in spot buyer bids
- Tech giants lose $1 trillion as AI bubble fears spark sell-off
- What Does OpenAI’s $20 Billion Deal Mean for Nvidia’s Future Profits?
- Are You Missing Out on the Big ETF Inflows? Spot the Potential in SPY, AMZN, GOOGL, GOOG!
Comments are closed.